Clinical Trial Update: Degarelix in the Treatment of Endometriosis Recurrence [Phase 3]

View source ↗

Summary

Phase 3 trial update on degarelix for treatment of endometriosis recurrence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• degarelix (degarelix)

Snippet

Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy | Conditions: Endometriosis | Phase 3 | Status: COMPLETED